274
Views
116
CrossRef citations to date
0
Altmetric
Original Research

Synthesis and characterization of silver/montmorillonite/chitosan bionanocomposites by chemical reduction method and their antibacterial activity

, , , , , & show all
Pages 271-284 | Published online: 27 Jan 2011

Abstract

Silver nanoparticles (AgNPs) of a small size were successfully synthesized using the wet chemical reduction method into the lamellar space layer of montmorillonite/chitosan (MMT/Cts) as an organomodified mineral solid support in the absence of any heat treatment. AgNO3, MMT, Cts, and NaBH4 were used as the silver precursor, the solid support, the natural polymeric stabilizer, and the chemical reduction agent, respectively. MMT was suspended in aqueous AgNO3/Cts solution. The interlamellar space limits were changed (d-spacing = 1.24–1.54 nm); therefore, AgNPs formed on the interlayer and external surface of MMT/Cts with d-average = 6.28–9.84 nm diameter. Characterizations were done using different methods, ie, ultraviolet-visible spectroscopy, powder X-ray diffraction, transmission electron microscopy, scanning electron microscopy, energy dispersive X-ray fluorescence spectrometry, and Fourier transform infrared spectroscopy. Silver/montmorillonite/chitosan bionanocomposite (Ag/MMT/Cts BNC) systems were examined. The antibacterial activity of AgNPs in MMT/Cts was investigated against Gram-positive bacteria, ie, Staphylococcus aureus and methicillin-resistant S. aureus and Gram-negative bacteria, ie, Escherichia coli, E. coli O157:H7, and Pseudomonas aeruginosa by the disc diffusion method using Mueller Hinton agar at different sizes of AgNPs. All of the synthesized Ag/MMT/Cts BNCs were found to have high antibacterial activity. These results show that Ag/MMT/Cts BNCs can be useful in different biological research and biomedical applications, including surgical devices and drug delivery vehicles.

Introduction

In recent years, silver nanoparticles (AgNPs) have attracted considerable attention for medical and chemical applications due to their exceptional properties, including antibacterial activity, high resistance to oxidation, and high thermal conductivity.Citation1Citation5 Recently, different inorganic antibacterial materials, including AgNPs, have been expanded and some are in commercial use.Citation6 The antibacterial activity of AgNPs-containing materials can be used, for example, in medicines to treat infections in human skin,Citation7,Citation8 dental materials,Citation9 catheters,Citation10,Citation11 vascular grafts,Citation12 stainless steel materials,Citation13 arthroplasty,Citation14 and burn treatment,Citation15,Citation16 as well as to prevent microorganism colonization on prostheses.Citation17 In addition, nanomaterials including AgNPs can be utilized for water treatmentCitation18 and also for reducing bacteria on textile fabrics.Citation19,Citation20 AgNPs also have effective cytoprotective activity towards human immunodeficiency virus-infected cells.Citation21 Because of this broad variety of applications, many preparation methods have been developed. In addition to the bactericidal effects of Ag+ ions, the antimicrobial activity of colloid AgNPs is influenced by the size of the particles, ie, the smaller the particles, the greater the antimicrobial effect.Citation22Citation28 Therefore, in developing methods for AgNP preparation, it is important to control the size of the AgNP particles. AgNPs of small size and devoid of aggregation properties are favorable for this purpose.

Chemical reduction methods have been widely investigated for the synthesis of AgNPs because these techniques can be executed under easy and gentle conditions, and can be used to synthesize AgNPs on a large scale. The reducing capability of a reductant has a significant role in the synthesis of AgNPs by the reduction reaction. The use of a strong reducing agent, such as NaBH4, results in tiny particles that are well dispersed.Citation29

Nowadays, a succession of chemical reductants can been used for the synthesis of noble metal nanoparticles which contain NaBH4,Citation30,Citation31,Citation36 NH2OH,Citation32 N2H4,Citation33,Citation36 (CH3)2 NH.BH3,Citation34 H2,Citation35 formaldehyde,Citation36 formamide,Citation37 Tollens’ reagents,Citation38 ethylene glycol,Citation39 ethanol,Citation40 citrate,Citation32,Citation40 aniline,Citation41 polyaniline,Citation42 or ascorbic acid.Citation43

Layered silicates, eg, montmorillonite (MMT), have been used in polymer nanocomposites with a significant improvement in mechanical properties.Citation44,Citation45 MMT possesses a 2-to-1 layered structure with a single octahedral aluminum layer located between two layers of tetrahedral silicon.Citation46 Each layer is about 1 nm thick with a lateral dimension of 100–1000 nm.Citation47 Furthermore, being a lamellar clay, MMT has intercalation, swelling, and ion exchange properties.Citation48 MMT can be delaminated into elemental sheets without difficulty. Therefore, it is tempting to utilize these sheets as the substrate for preparation of nanoscale metals by means of electrodeless plating. The MMT interlayer space has been used for the synthesis of material and biomaterial nanoparticles as the support for anchoring transition metal complexes and as adsorbents for cationic ions.Citation49,Citation50

Among the natural polymers, chitosan (Cts) has been extensively investigated as a natural cationic biopolymer because of its excellent biocompatibility, biodegradability, nontoxicity, bioactivity, and multifunctional groups, as well as its solubility in aqueous medium for food packaging film, bone substitutes, and artificial skin.Citation51 Cts can be intercalated in MMT by cationic exchange and hydrogen bonding processes, whereby the resulting bionanocomposites (BNCs) show interesting structural and functional properties.Citation52 Conversely, BNCs are made of a natural polymeric matrix and inorganic/organic filler with at least one dimension on the nanometer scale. Metal/clay/polymer compounds like BNCs with their excellent properties have become a promising new areas of research.Citation53

Furthermore, AgNPs have long been known to have strong inhibitory and bactericidal effects, as well as a broad spectrum of antimicrobial activity, and have been used for centuries to prevent and treat a variety of diseases, most notably infections. AgNPs were reported recently as having antibacterial activity against Escherichia coli, Staphylococcus aureus, methicillin-resistant Staphylococcus epidermis, and methicillin-resistant S. aureus (MRSA) bacteria.Citation53Citation55 AgNPs also exhibit potent cytoprotective activity towards cells infected with human immunodeficiency virus.Citation56 The application of AgNPs for biological labelling in neuroblastoma cells was recently reported. Due to the strong plasmon-resonant properties of AgNPs and the enhanced resolution obtainable with high-illumination systems in physiological solution, studies of the interactions between AgNPs and human cells have been possible.Citation57 Hence, similar studies on Ag/poly(lactic acid),Citation30 Ag/MMT,Citation48,Citation59 Ag/talc,Citation58 Ag/MMT/starch BNCsCitation60 and Ag/MMT/Cts BNCs,Citation61,Citation62 have been undertaken previously.

In this research, the spherical structure of AgNPs was synthesized in the interlayer surface of the MMT layers modified with a low percentage of Cts in aqueous solution by using AgNO3, Cts, and NaBH4 as the silver precursor, the stabilizer, and the reduction agent, respectively, at room temperature. We used modified clay (MMT/Cts) as the protective colloid to prevent the AgNPs from aggregating, and it was found that MMT/Cts also assisted in the chemical reduction process of silver. Needless to say, to date, there has not been any report of a study of Ag/MMT/Cts BNCs using a chemical reduction method, ie, lamellar polymeric silicate, which is the subject of this research. In addition, the antibacterial activity of AgNO3/MMT/Cts and Ag/MMT/Cts BNCs were investigated and compared. Using this method, we were able to obtain AgNPs of different sizes and dissimilar antibacterial activity by controlling the AgNO3 concentration.

Materials and methods

Chemicals

All reagents in this work were of analytical grade and used as received without further purification. AgNO3 (99.98%), used as the silver precursor, was obtained from Merck (Darmstadt, Germany). Meanwhile, the MMT powder, used as a solid support for the AgNPs, was purchased from Kunipia-F (Tokyo, Japan). NaBH4 (98.5%), low-molecular-weight Cts, and glacial acetic acid (99%) used as a reduction agent, a stabilizer, and for solubilizing Cts, respectively, were obtained from Sigma-Aldrich (St Louis, MO). All the aqueous solutions were used with double-distilled water.

Synthesis of Ag/MMT/Cts BNCs using NaBH4

For the synthesis of Ag/MMT/Cts BNCs, soluble Cts (100 mL, 0.5 wt%) was prepared by solubilization in 1.0 wt% of acetic acid solution (pH ~3.53) under constant stirring for 45 minutes, for each of the samples. Following the usual preparation method for AgNPs, AgNO3 solutions were added to each soluble Cts sample under constant stirring for synthesis of the AgNO3/Cts solutions. The aqueous Cts-acetic acid solution thickened after the addition of AgNO3 solution. The Ag content of the samples was 0.5 (A1), 1.0 (A2), 1.5 (A3), 2.0 (A4), and 5.0 g (A5) Ag/100 g MMT. Constant amounts of MMT were suspended in different volumes of 1 × 10−3 M AgNO3 solution with soluble Cts and stirred for 24 hours at room temperature to obtain the AgNO3/MMT/Cts suspensions. Freshly prepared NaBH4 (4 × 10−2 M) solution was then added to the suspensions under continuous stirring to reach a constant AgNO3/NaBH4 molar ratio (1:4). After the addition of the reducing agent, stirring was continued for another hour. The suspensions of Ag/MMT/Cts BNCs obtained were then centrifuged, washed four times using double-distilled water to remove the silver ion residue, and dried at 40°C under vacuum overnight. All the experiments were conducted at ambient temperature.

Evaluation of antibacterial activity

The in vitro antibacterial activity of the samples was evaluated by the disc diffusion method using Mueller Hinton agar with determination of inhibition zones, which conformed to the recommended standards of the National Committee for Clinical Laboratory Standards (now known as the Clinical and Laboratory Standards Institute, 2000). E. coli (ATCC 25922), E. coli O157:H7 (ATCC 43895), Pseudomonas aeruginosa (ATCC 10145), S. aureus (ATCC 25923), and MRSA (ATCC 700689) were used for the antibacterial assay. Briefly, 6 mm sterile paper discs impregnated with 20 μL of Ag/MMT/Cts BNCs (A2, A4, and A5) with different treatment times were suspended in the sterile distilled water and left to dry at 37°C for 24 hours under sterile conditions. The bacterial suspension was prepared by making a saline suspension of isolated colonies selected over 18–24 hours of tryptic soy agar plate. The suspension was adjusted to match the tube of 0.5 McFarland turbidity standard using the spectrophotometer at 600 nm, which is equivalent to 1.5 × 108 colony-forming units/mL. The surface of the Mueller Hinton agar was completely inoculated using a sterile swab, and was then steeped in the prepared suspension of bacterium. Finally, the impregnated discs were placed on the inoculated agar and incubated at 37°C for 24 hours. After incubation, the diameter of the growth inhibition zones was measured. Chloramphenicol 30 μg and cefotaxime 30 μg were used as the positive standards in order to control the sensitivity of the bacteria. All tests were done in triplicate.

Characterization methods and instruments

The prepared Ag/MMT/Cts BNCs were characterized by ultraviolet (UV)-visible spectroscopy, powder X-ray diffraction (PXRD), transmission electron microscopy (TEM), scanning electron microscopy (SEM), energy dispersive X-ray fluorescence spectrometry (EDXRF), inductively coupled plasma-optical emission spectrophotometer (ICP-OES), and Fourier transform infrared (FT-IR) spectroscopy. The UV-visible spectra were recorded over the 300–700 nm range utilising the Shimadzu H.UV.1650 PC spectrophotometer. The structures of the Ag/MMT/Cts BNCs produced were examined by powder X-ray diffraction using the Shimadzu PXRD-6000. Changes in the interlamellar spacing of MMT and Ag/MMT/Cts BNCs were also studied by PXRD in the angle range of 2° < 2θ < 12°. In addition, the interlamellar spaces were calculated from the PXRD peak positions using Bragg’s law. A wavelength (λ) of 0.15418 nm was used for these measurements. The PXRD patterns were recorded at a scan speed of 2° min−1. TEM observations were carried out on a H-7100 electron microscope (Hitachi, Tokyo, Japan), and the particle size distributions were determined using the UTHSCSA Image Tool program (version 3.00; Dental Diagnostic Science, UTHSCSA, San Antonio, TX). SEM was performed using the Philips XL-30 instrument (Philips, Eindhoven, The Netherlands) to study the morphology of MMT, MMT/Cts, and Ag/MMT/Cts BNCs (A2, A4, and A5). EDXRF was carried out on a EDX-700HS spectrometer (Shimadzu, Osaka, Japan). Elemental analysis of the synthesized AgNPs was quantified using an ICP-OES, model Optima 2000DV (Perkin Elmer, Waltham, MA). Meanwhile, the FT-IR spectra were recorded over the range of 400–4000 cm−1 using the Series 100 Perkin Elmer FT-IR 1650 spectrophotometer. After the reactions, the samples were centrifuged using a high-speed centrifuge machine (Avanti J25; Beckman, Brea, CA).

Results and discussion

To prepare the stable AgNPs via the wet chemical reduction method, it was important to choose a suitable stabilizer and reducing agent. In this research, a MMT/Cts suspension was used as the appropriate support for reducing AgNO3/MMT/Cts suspension, and using NaBH4 as the strong reducing agent. AgNO3 was reduced by NaBH4 in the presence of MMT hydride with Cts (MMT/Cts), resulting in AgNPs prepared according to the following equation:Citation63

Ag+/MMT/Cts+BH4-+3H2OAg0/MMT/Cts+B(OH)3+3.5H2

The schematic illustration of the synthesis of Ag/MMT/Cts BNCs from AgNO3/MMT/Cts produced using NaBH4 as the chemical reduction agent is shown in . Meanwhile, as shown in , the MMT and AgNO3/MMT/Cts suspensions (A0) were colorless, but after the addition of the reducing agent to the suspensions, they turned light brown (A1), brown (A2), reddish-brown (A3), and dark brown (A4 and A5), indicating the formation of AgNPs in the MMT/Cts suspensions. The formation of AgNPs was also followed by measuring the surface plasmon resonance bands of the AgNO3/MMT/Cts (A0) and Ag/MMT/Cts BNCs suspensions (A1–A5) at wavelengths in the 300–700 nm range (). The comparison between the PXRD patterns of MMT, MMT/Cts, and Ag/MMT/Cts BNCs (A1, A2, and A5) in the small angle range of 2θ (2° < 2θ < 12°) indicated the formation of the intercalated AgNPs structure (). In addition, the PXRD patterns in the wide angle range of 2θ (30° < 2θ < 80°) were also employed to determine the crystalline structures of the synthesized AgNPs (). The TEM images and size distribution of the AgNPs showed that the mean diameter of the nanoparticles ranged from about 6.28 nm to 9.84 nm (). As shown in and , the SEM images indicated that there were no structural changes between the initial MMT, MMT/Cts, and Ag/MMT/Cts BNCs (A2, A4, and A5) at different AgNO3 concentrations. In addition, the EDXRF spectra for the MMT, MMT/Cts and Ag/MMT/Cts BNCs (A2, A4, and A5) confirmed the presence of elemental compounds in MMT, Cts, and AgNPs without any other impurity peaks ( and ). The chemical structures of MMT, MMT/Cts, and Ag/MMT/Cts BNCs (A2, A4, and A5) were analyzed by FT-IR spectroscopy ( and ). The approximate efficiency gradually increased from A1 to A5, respectively ().

Table 1 Physical properties of silver nanoparticles in silver/montmorillonite/chitosan bionanocomposites synthesised at different AgNO3 concentrations: (A1) 0.5%, (A2) 1.0%, (A3) 1.5%, (A4) 2.0%, and (A5) 5.0%

The antibacterial studies showed comparatively similar effects for all samples, as indicated by the inhibition zone test between Cts, MMT/Cts, MMT, AgNO3/MMT/Cts (A0), and Ag/MMT/Cts BNCs (A2, A4, and A5) against different bacteria (, ).

Table 2 Average inhibition zone and standard deviation for montmorillonite, chitosan, montmorillonite/chitosan, silver/montmorillonite/chitosan bionanocomposites (A0), and silver/montmorillonite/chitosan bionanocomposites at different AgNO3 concentrations: (A2) 1.0%, (A4) 2.0%, and (A5) 5.0%

Figure 1 Schematic illustration of the synthesized silver/montmorillonite/chitosan bionanocomposites from silver nitrate/montmorillonite/chitosan (A0) by a chemical reduction method.

Abbreviations: AgNPs, silver nanoparticles.

Figure 1 Schematic illustration of the synthesized silver/montmorillonite/chitosan bionanocomposites from silver nitrate/montmorillonite/chitosan (A0) by a chemical reduction method.Abbreviations: AgNPs, silver nanoparticles.

Figure 2 Photograph of montmorillonite/chitosan bionanocomposite suspension (A0) and silver/montmorillonite/chitosan bionanocomposite suspension at different AgNO3 concentrations; (A1) 0.5%, (A2) 1.0%, (A3) 1.5%, (A4) 2.0%, and (A5) 5.0%.

Figure 2 Photograph of montmorillonite/chitosan bionanocomposite suspension (A0) and silver/montmorillonite/chitosan bionanocomposite suspension at different AgNO3 concentrations; (A1) 0.5%, (A2) 1.0%, (A3) 1.5%, (A4) 2.0%, and (A5) 5.0%.

Figure 3 Ultraviolet-visible absorption spectra of silver/montmorillonite/chitosan bionanocomposite suspension for different AgNO3 concentrations: (A1) 0.5%, (A2) 1.0%, (A3) 1.5%, (A4) 2.0%, (A5) 5.0%, and (A0) silver nitrate/montmorillonite/chitosan bionanocomposite suspension in the absence of sodium borohydride.

Figure 3 Ultraviolet-visible absorption spectra of silver/montmorillonite/chitosan bionanocomposite suspension for different AgNO3 concentrations: (A1) 0.5%, (A2) 1.0%, (A3) 1.5%, (A4) 2.0%, (A5) 5.0%, and (A0) silver nitrate/montmorillonite/chitosan bionanocomposite suspension in the absence of sodium borohydride.

Figure 4 Powder X-ray diffraction patterns of montmorillonite, montmorillonite/chitosan, and silver/montmorillonite/chitosan bionanocomposites for determination of d-spacing at different AgNO3 concentrations: (A2) 1.0%, (A4) 2.0%, and (A5) 5.0%.

Abbreviations: Cts, chitosan; MMT, montmorillonite.

Figure 4 Powder X-ray diffraction patterns of montmorillonite, montmorillonite/chitosan, and silver/montmorillonite/chitosan bionanocomposites for determination of d-spacing at different AgNO3 concentrations: (A2) 1.0%, (A4) 2.0%, and (A5) 5.0%.Abbreviations: Cts, chitosan; MMT, montmorillonite.

Figure 5 Powder X-ray diffraction patterns of montmorillonite and silver/montmorillonite/chitosan bionanocomposites for determination of silver crystals at different AgNO3 concentrations: (A1) 0.5%, (A2) 1.0%, (A3) 1.5%, (A4) 2.0%, and (A5) 5.0%.

Abbreviation: MMT, montmorillonite.

Figure 5 Powder X-ray diffraction patterns of montmorillonite and silver/montmorillonite/chitosan bionanocomposites for determination of silver crystals at different AgNO3 concentrations: (A1) 0.5%, (A2) 1.0%, (A3) 1.5%, (A4) 2.0%, and (A5) 5.0%.Abbreviation: MMT, montmorillonite.

Figure 6 Transmission electron microscopy images and corresponding particle size distribution of silver/montmorillonite/chitosan bionanocomposites at different AgNO3 concentrations: 1.0% (A, B), 2.0% (C, D), and 5.0% (E, F).

Figure 6 Transmission electron microscopy images and corresponding particle size distribution of silver/montmorillonite/chitosan bionanocomposites at different AgNO3 concentrations: 1.0% (A, B), 2.0% (C, D), and 5.0% (E, F).

Figure 7 Scanning electron microscopy micrographs and energy dispersive X-ray fluorescence spectra for montmorillonite (A, B) and montmorillonite/chitosan (C, D), respectively.

Abbreviations: Cts, chitosan; MMT, montmorillonite.

Figure 7 Scanning electron microscopy micrographs and energy dispersive X-ray fluorescence spectra for montmorillonite (A, B) and montmorillonite/chitosan (C, D), respectively.Abbreviations: Cts, chitosan; MMT, montmorillonite.

Figure 8 Scanning electron micrographs and energy dispersive X-ray fluorescence spectra, respectively, for the silver/montmorillonite/chitosan bionanocomposites at different AgNO3 concentrations: 1.0% (A), 2.0% (B), 5.0% (C), and (D).

Abbreviation: AgNPs, silver nanoparticles.

Figure 8 Scanning electron micrographs and energy dispersive X-ray fluorescence spectra, respectively, for the silver/montmorillonite/chitosan bionanocomposites at different AgNO3 concentrations: 1.0% (A), 2.0% (B), 5.0% (C), and (D).Abbreviation: AgNPs, silver nanoparticles.

Figure 9 Fourier transform infrared spectra for chitosan (A), montmorillonite/chitosan (B), and montmorillonite (C), respectively.

Figure 9 Fourier transform infrared spectra for chitosan (A), montmorillonite/chitosan (B), and montmorillonite (C), respectively.

Figure 10 Fourier transform infrared spectra for the silver/montmorillonite/chitosan bionanocomposites at different AgNO3 concentrations: (A2) 1.0% (A), (A4) 2.0% (B), and (A5) 5.0% (C).

Figure 10 Fourier transform infrared spectra for the silver/montmorillonite/chitosan bionanocomposites at different AgNO3 concentrations: (A2) 1.0% (A), (A4) 2.0% (B), and (A5) 5.0% (C).

Figure 11 Comparison of the inhibition zone test between Gram-negative and Gram-positive bacteria, ie, Escherichia coli (A), E. coli O157:H7 (B), Pseudomonas aeruginosa (C), Staphylococcus aureus (D), and methicillin-resistant S. aureus (E).

Abbreviations: Cts, chitosan; MMT, montmorillonite.

Figure 11 Comparison of the inhibition zone test between Gram-negative and Gram-positive bacteria, ie, Escherichia coli (A), E. coli O157:H7 (B), Pseudomonas aeruginosa (C), Staphylococcus aureus (D), and methicillin-resistant S. aureus (E).Abbreviations: Cts, chitosan; MMT, montmorillonite.

Ultraviolet-visible spectroscopy

The color of the AgNO3/MMT/Cts suspensions through the reduction process using NaBH4 changed from colorless to light brown, brown, reddish-brown, and, finally, dark brown (A1–A5), respectively, which indicated the formation of AgNPs in the MMT/Cts suspension. The silver surface plasmon resonance bands were detected around 391–408 nm (). These absorption bands were assumed to correspond to AgNPs smaller than 10 nm.Citation64 While there was no UV-visible absorption of AgNPs before the addition of NaBH4 in A0 (), the growth of the plasmon peak at 391 nm indicated the formation of AgNPs in A1. Furthermore, the gradual increase in the AgNO3 concentration from A1 to A4 also increased the corresponding peak intensities in the wavelength range of 391–403 nm. In A5, the absorption peak due to surface plasmon resonance of Ag+ was slightly red-shifted to a higher wavelength (408 nm), which indicated the increase in size of the AgNPs.Citation65,Citation66

Powder X-ray diffraction

As shown in , the original d-spacing (dS) of MMT (1.24 nm) and in MMT/Cts, was increased to 1.45 nm at the small 2θ angles (2θ = 7.12° for MMT and 2θ = 6.09° for MMT/Cts) by Cts intercalation. The dS in A2, A4, and A5 also increased gradually from 1.49 nm to 1.51 nm and finally to 1.54 nm at the 2θ angles (2θ = 5.98° [A1], 2θ = 5.96° [A4], and 2θ = 5.90° [A5]) by Ag/Cts intercalation between MMT layers. These dS values were direct proof of the intercalation structures. The AgNPs formed at the latter location were the cause of the increase in basal spacing. In these samples, the intensities of the reflections were significantly lower, whereas their half-widths were larger than those of undoped clay minerals, whereby the highly ordered parallel lamellar structure of the mineral was disrupted by metal nanoparticle formation.Citation67 In addition, all the Ag/MMT/Cts BNCs (A1–A5) had a similar diffraction profile, and the PXRD peaks at 2θ of 38.32°, 44.48°, 64.62°, and 77.60° () could be attributed to the 111, 200, 220, and 311 crystallographic planes of the face-centered cubic silver crystals, respectively. Citation68 For all samples, the main crystalline phase was silver, and no other obvious phases were found as impurities in the PXRD patterns. Moreover, the PXRD peak broadenings of the AgNPs were mostly due to the existing nanosized particles in the BNPs. In addition, there was a characteristic peak at about 2θ = 62.30° related to the MMT clay (PXRD Ref No 00–003–0010) as a stable substrate. The intensities of 111, 200, 220, and 311 reflections due to the AgNP phase were also found to increase along with the increased AgNPs in the solid support matrix content stabilizer (MMT/Cts) by the wet chemical reduction method.

Morphology

The TEM images and their corresponding particle size distributions for the Ag/MMT/Cts BNCs containing different percentages of AgNPs are shown in . The TEM images and their size distributions reveal that the mean diameters and standard deviation of the AgNPs were about 6.28 ± 3.54, 8.29 ± 3.18, and 9.84 ± 2.51 nm for 1.0% (A–B), 2.0% (C–D) and 5.0% (E–F), respectively. These results showed that the diameters of the AgNPs synthesized by this method depended on the initial AgNO3 concentration. SEM images of the MMT, MMT/Cts, and Ag/MMT/Cts (A2, A4, and A5) are presented in and . The surface morphology of MMT demonstrates a layered surface with some large flakes, which is the typical structure for MMT (). The exterior morphology of the MMT/Cts and Ag/MMT/Cts BNCs (A2, A4, and A5), show layered surfaces with large flakes and without significant morphological differences between them. Furthermore, the external surfaces of Ag/MMT/Cts BNCs (A2, A4, and A5) gradually become more shiny due to the presence and increase of AgNP amounts (). shows the EDXRF spectra for the MMT and MMT/Cts. The peaks at around 1.7, 2.7, 2.9, 3.7, 4.0, 4.5, 6.4, and 7.1 keV are related to the binding energies of MMT, and peaks at around 8.1, 8.7, and 9.6 keV correspond to the binding energies of Cts. In , the peaks around 1.3, 3.1, 3.3, and 3.4 keV are related to Ag+ elements in A2, A4, and A5.Citation69 In addition, the EDXRF spectra for the MMT, MMT/Cts, and Ag/MMT/Cts BNCs (A2, A4, and A5) confirmed the presence of elemental compounds in the MMT, Cts, and AgNPs without any impurity peaks. also demonstrates that, with the increased percentages of AgNPs in MMT/Cts (1%, 2%, and 5%) and after reduction, the intensity of AgNP peaks in the EDXRF spectra increased. The results indicate that the synthesized BNCs are composed of high-purity Cts and AgNPs.

Chemical analysis by Fourier transform infrared spectroscopy

The FT-IR spectrum of MMT () show the vibration bands at 3633 cm−1 for O-H stretching, 3447 cm−1 due to the interlayered O-H stretching (H bonding), at 1652 and 1531 cm−1 for H-O-H bending, 1126, 1011, and 910 cm−1 for Si-O stretching, 624 cm−1 for Al-OH, 910 cm−1 due to (Al, Mg)-OH vibration modes and 527 and 446 cm−1 for Si-O bending.Citation70 The spectrum of Cts () show peaks at 3375 and 3320 cm−1 due to the overlapping of O-H and N-H stretching bands, ie, 2900 cm−1 for aliphatic C-H stretching, 1652 and 1612 cm−1 for N-H bending, 1434, 1386, and 1333 cm−1 for C-H bending, and 1051 cm−1 for C-O stretching. The spectrum of MMT/Cts () shows a combination of characteristic absorptions due to MMT and the amine groups of Cts. The peaks of the external vibration and interlayered stretching O-H groups in MMT and MMT/Cts were relatively constant at 3634, and a little shifted to low wave numbers in 3424 cm−1. On the other hand, the peaks of aliphatic C-H and -NH2 groups in pure Cts at 2900, 1652, and 1612 cm−1 were shifted to 2887, 1647, and 1538 cm−1 in the MMT/Cts, corresponding to the deformation vibration of the amine group of Cts.Citation71,Citation72 These results appeared to be in agreement with the data from PXRD, revealing the intercalation of Cts in the MMT structure.

As shown in , there were changes in the spectra of Ag/MMT/Cts BNCs compared with MMT/Cts () and peaks in A2, A4, and A5 shifted to lower wave numbers. The FT-IR spectra demonstrated the inflexibility of the silicate layers and the nonbonding chemical interface between the silicate layers and AgNPs in Ag/MMT/Cts BNCs (A2, A4, and A5). The interactions between the silicate layers of MMT and Cts were related to the peaks at the high and low wave numbers. For example in A2, a peak at 2946 cm−1 is associated with aliphatic C-H stretching, at 1649 cm−1 is related to the overlap Cts peaks in 1652 and 1612 cm−1, with a MMT peak in 1652 cm−1. Moreover, peaks appear in 1448, 1396, and 1330 cm−1 connected with C-H bending, similar to the Cts peaks. Broad peaks were due to the presence of van der Waals interactions between the hydroxyl, amine, and C-H bending groups of Cts intercalated to the MMT layers with a partial positive charge on the surface of the AgNPs.Citation61 These results confirm that, with the increased amounts of AgNPs in the Ag/MMT/Cts BNCs (A2, A4, and A5), respectively, due to the existence of complexation peaks between the Cts groups and AgNPs, the peaks are shifted to low wave numbers and the peak intensity is increased.

Inductively coupled plasma-optical emission spectroscopy

The ICP-OES analyzer was used to determine the approximate efficiency of AgNO3/MMT/Cts suspension reduction by NaBH4 to Ag/MMT/Cts BNCs. A modified digestion method was used to quantify the amount of AgNP conversion to Ag+ in the MMT/Cts. An air-dried mass of each Ag/MMT/Cts BNC sample (A1–A5) was submerged in a solution of 10 mL of ultrapure reagent grade nitric acid (364576, grade >90%; Sigma-Aldrich), and 10 mL of double-distilled water. After the samples were placed over the digestion beakers, the solutions were heated to approximately 80°C for 15 minutes and allowed to react. The digestion solutions were allowed to cool in room temperature and then filtered through a glass fiber filter (Qualitative #2; Whatman, Florham Park, NJ) and diluted in 100 mL in volumetric flasks.Citation73 After detecting the Ag+ ions by ICP-OES spectroscopy, with the increased concentration of AgNO3 in the MMT/Cts matrix and then the reduction by the reducing agent, the approximate efficiency gradually decreased from 97.20% to 95.35%, 92.47%, 88.53%, and, finally, 83.50% after A1, A2, A3, A4, and A5, respectively (). The results from the ICP-OES analysis using a strong reduction agent confirmed the formation of AgNPs in MMT/Cts, which produced high yields.

Antibacterial activity

Inhibition zone values were obtained for the synthesized AgNO3/MMT/Cts suspension and Ag/MMT/Cts BNCs (A2, A4, and A5) tested against E. coli, E. coli O157:H7, P. aeruginosa, S. aureus, and MRSA. The results and images of the inhibition zones are presented as average values in and , respectively. shows that the AgNO3 and AgNPs in MMT/Cts suspension had high and similar antibacterial activity against Gram-negative and Gram-positive bacteria. Because of their size, AgNPs can easily reach the nuclear content of bacteria and they show a large and impressive surface area, where contact with bacteria is the greatest.Citation74,Citation75 This could be the reason why these nanoparticles have the best antibacterial effect. For solid support systems, some researchers argue that Ag+ ions released from the surface of AgNPs are responsible for their antibacterial activity.Citation76,Citation77 For aqueous phase systems, the results show that the antibacterial test of Ag+ ions is not high at the concentration levels reached by release, and the presence of AgNPs is very important, which reinforces the idea that the larger the surface area, the greater the antibacterial activity.Citation78 The diameters of the inhibition zones in agar plates are given in mm. The tests were repeated three times for each treated sample, and the results are presented in . The suspensions of MMT (10 mg/mL), soluble Cts (0.5 mg/mL), and MMT/Cts did not show any antibacterial activity. The AgNO3/MMT/Cts suspension for all tested bacteria shows high antibacterial activity and, interestingly, these effects in the Ag/MMT/Cts BNCs (A2, A4, and A5) were increased with decreasing size of AgNPs. However, this research also showed that the amounts of AgNPs gradually were increased in the Ag/MMT/Cts BNCs (A2, A4, and A5), but higher AgNPs loading does not lead to superior antibacterial activity.

Conclusion

AgNPs were successfully prepared from AgNO3/MMT/Cts suspension at different AgNO3 concentrations by using NaBH4 as a chemical reduction agent in the interlamellar space and external layer surface of MMT modified with Cts without any heat treatment or reducing agent. These AgNPs were found to be stabilized by the low molecular weight of Cts. In addition, the distribution size of AgNPs prepared at different concentrations of AgNO3 indicate that larger particle sizes of AgNPs were obtained when the Ag+ ion concentration increased. The average diameters of the AgNPs were around 6.28, 8.29, and 9.84 nm for A2, A4, and A5, respectively. Moreover, the PXRD analysis confirmed that the crystallographic planes of the silver crystals were of the face-centered cubic type. The UV-visible absorption spectra showed the peak characteristics of the surface plasmon resonance bond of AgNPs. SEM images show that the external morphology for MMT, MMT/Cts and Ag/MMT/Cts BNCs (A2, A4, and A5) have layered surfaces with large flakes, with no noteworthy morphological distinctions between them. Also, due to the presence of AgNPs in the external and internal surfaces of Ag/MMT/Cts BNCs, these layers become shiny. EDXRF spectra confirmed the presence of elemental compounds in the MMT, Cts, and AgNPs without any contamination peaks. The antibacterial activities of Ag/MMT/Cts BNCs at the different AgNP particle sizes showed strong antibacterial activity against Gram-positive and Gram-negative bacteria. These results show that the antibacterial resistance of AgNPs in MMT/Cts can be modified according to the size of AgNPs, and decreases with increased particle size. Further studies are required to investigate the bactericidal effects of Ag/MMT/Cts BNCs against different types of bacteria for potential widening of their applications, such as in surgical devices and in drug-delivery vehicles.

Acknowledgments

The authors are grateful to the staff of the Department of Chemistry, Universiti Putra Malaysia, for their help with this research, and to the Institute of Bioscience, Universiti Putra Malaysia, for technical assistance.

Disclosure

The authors have no conflicts of interest to disclose in this work.

References

  • CarotenutoGPepeGPNicolaisLPreparation and characterization of nano-sized Ag/PVP composites for optical applicationsEur Phys J B2000161117
  • StathatosELianosPPhotocatalytically deposited silver nanoparticles on mesoporous TiO2 filmsLangmuir20001623982400
  • KyriacouSVBrownlowWJXuXNUsing nanoparticle optics assay for direct observation of the function of antimicrobial agents in single live bacterial cellsBiochemistry20044314014714705939
  • FengXMaHHuangSAqueous-organic phase-transfer of highly stable gold, silver, and platinum nanoparticles and new route for fabrication of gold nanofilms at the oil/water interface and on solid supportsJ Phys Chem B2006110123111231716800553
  • ChoiSKimKSYeonSHFabrication of silver nanoparticles via self-regulated reduction by 1-(2-hydroxyethyl)-3-methylimidazolium tetrafluoroborateKorean J Chem Eng200724856859
  • KawashitaMTsuneyamaSMijajiFAntibacterial silver-containing silica glass prepared by the sol-gel methodBiomaterials20002139339810656321
  • GaugerAMempelMSchekatzASilver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczemaDermatology2003207152112835542
  • LeeHJJeongSHBacteriostasis and skin innoxiousness of nanosize silver colloids on textile fabricsText Res J200575551556
  • OhashiSSakuSYamamotoKJAntibacterial activity of silver inorganic agent YDA fillerOral Rehabil200431364367
  • RuppMEFitzgeraldTMarionNEffect of silver-coated urinary catheters: Efficacy, cost-effectiveness, and antimicrobial resistanceAm J Infect Control20043244545015573050
  • SamuelUGuggenbichlerJPPrevention of catheter-related infections: The potential of a new nano-silver impregnated catheterInt J Antimicrob Agents2004237578
  • StrathmannMWingenderJUse of an oxonol dye in combination with confocal laser scanning microscopy to monitor damage to Staphylococcus aureus cells during colonisation of silver-coated vascular graftsInt J Antimicrob Agents20042423424015325426
  • BosettiMMasseATobinESilver coated materials for external fixation devices: In vitro biocompatibility and genotoxicityBiomaterials20022388789211771707
  • AltVBechertTSteinrückePAn in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cementBiomaterials2004254383439115046929
  • UlkurEOnculOKaragozHComparison of silver-coated dressing (Acticoat™), chlorhexidine acetate 0.5% (Bactigrass®), and fusidic acid 2% (Fucidin®) for topical antibacterial effect in methicillin-resistant staphylococci-contaminated, full-skin thickness rat burn woundsBurns20053187487716011879
  • ParikhDVFinkTRajasekharanKAntimicrobial silver/sodium carboxymethyl cotton dressings for burn woundsText Res J200575134138
  • GoshegerGHardesJAhrensHSilver-coated megaendoprostheses in a rabbit model an analysis of the infection rate and toxicological side effectsBiomaterials2004255547555615142737
  • ChouWLYuDGYangMCThe preparation and characterization of silver-loading cellulose acetate hollow fiber membrane for water treatmentPolym Adv Technol200516600607
  • YuranovaTRinconAGBozziAAntibacterial textiles prepared by RF-plasma and vacuum-UV mediated deposition of silverPhotochem Photobiol A20031612734
  • JeongSHYeoSYYiSCThe effect of filler particle size on the antibacterial properties of compounded polymer/silver fibersJ Mater Sci20054054075411
  • SunRWYChenRChungNPYSilver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cellsChem Commun20054050595061
  • MatijevicEPreparation and properties of uniform size colloidsChem Mater19935412426
  • NickelUCastellAZPopplKA silver colloid produced by reduction with hydrazine as support for highly sensitive surface-enhanced raman spectroscopyLangmuir20001690879091
  • LeopoldNLendlBJA new method for fast preparation of highly surface-enhanced raman scattering (SERS) active silver colloids at room temperature by reduction of silver nitrate with hydroxylamine hydrochloridePhys Chem B200310757235727
  • KhannaPKSubbaraoVVVSNanosized silver powder via reduction of silver nitrate by sodium formaldehydesulfoxylate in acidic pH mediumMater Lett20035722422245
  • SondiIGoiaDVMatijevicEJJPreparation of highly concentrated stable dispersions of uniform silver nanoparticlesColloid Interface Sci20032607581
  • MoronesJRElechiguerraJLCamachoAThe bactericidal effect of silver nanoparticlesNanotechnology2005162346235320818017
  • BakerCPradhanAPakstisLSynthesis and antibacterial properties of silver nanoparticlesNanosci Nanotechnol20055244249
  • YongKTSahooYSwihartMTSynthesis and plasmonic properties of silver and gold nanoshells on polystyrene cores of different size and of gold–silver core–shell nanostructuresColloids and Surfaces A200629089105
  • ShameliKAhmadMBYunusWMZWSilver/poly(lactic acid) nanocomposites: Preparation, characterization, and antibacterial activityInt J Nanomedicine2010557357920856832
  • ShenJShiMLiNFacile synthesis and application of Ag-chemically converted graphene nanocompositesNano Res20103339349
  • WuMLChenDHHuangTCEvidence for seed-mediated nucleation in the chemical reduction of gold salts to gold nanoparticlesChem Mater20011323132322
  • UnderhillRSLiuGPreparation and performance of Pd particles encapsulated in block copolymer nanospheres as a hydrogenation catalystChem Mater20001236333641
  • TorigoeKSuzukiAEsumiKAu (III)–PAMAM interaction and formation of Au–PAMAM nanocomposites in ethyl acetateJ Colloid Interface Sci2001241346356
  • HengleinAGiersigMReduction of Pt (II) by H2: Effects of citrate and NaOH and reaction mechanismJ Phys Chem B200010467676772
  • MayerABRGrebnerWWannemacherRPreparation of silver-latex compositesJ Phys Chem B200010472787285
  • HanMYQuekCHHuangWA simple and effective chemical route for the preparation of uniform nonaqueous gold colloidsChem Mater19991111441147
  • YinYLiZ-YZhongZSynthesis and characterization of stable aqueous dispersions of silver nanoparticles through the Tollens processJ Mater Chem200212522527
  • WangYRenJDengKPreparation of tractable platinum, rhodium, and ruthenium nanoclusters with small particle size in organic mediaChem Mater20001216221627
  • PathakSGreciMTKwongRCSynthesis and applications of palladium-coated poly(vinylpyridine) nanospheresChem Mater20001219851989
  • TanYLiYZhuDPreparation of silver nanocrystals in the presence of anilineJ Colloid Interface Sci200325824425112618093
  • WangJNeohKGKangETPreparation of nanosized metallic particles in polyanilineJ Colloid Interface Sci2001239788611397051
  • LimBJiangMYuTNucleation and growth mechanisms for Pd–Pt bimetallic nanodendrites and their electrocatalytic propertiesNano Res201036980
  • ChangaJHAnaYUChoDPoly (lactic acid) nanocomposites: Comparison of their properties with montmorillonite and synthetic mica (II)Polymer20034437153720
  • ChangJHAnYUSurGSPoly (lactic acid) nanocomposites with various organoclays. I. Thermomechanical properties, morphology, and gas permeabilityJ Polym Sci B Pol Phys20034194103
  • GiannelisEPKrishnamoortiRManiasEPolymer-silicate nanocomposites: Model systems for confined polymers and polymer brushesAdv Polym Sci1999138107147
  • RamsayJDFSwantonSWBunceJJSwelling and dispersion of smectite caly colloids: Determination of structure by neutron diffraction and small-angle neutron scatteringJ Chem Soc Faraday Trans19998639193926
  • AhmadMBShameliKDarroudiMSynthesis and characterization of silver/clay nanocomposites by chemical reduction methodAm J Appl Sci2009619091914
  • GaoYYunzhaoYDeposition of silver nanoparticles on montmorillonite platelets by chemical platingJ Mater Sci20023750835087
  • WangS-FShenLZhangW-DPreparation and mechanical properties chitosan/carbon nanotubes compositesBiomacromolecules200563067307216283728
  • DarderMColillaMRuiz-HitzkyEChitosan-clay nanocomposites: Application as electrochemical sensorsAppl Clay Sci200528199208
  • ZhouNLLiuYLiLA new nanocomposite biomedical material of polymer/clay-Cts-Ag nanocompositesCurr Appl Phys20077S15862
  • AhmadMBShameliKDarroudiMSynthesis and antibacterial activity of silver/montmorillonite nanocompositesRes J Biol Sci2009410321036
  • O’HanlonSJEnrightMCA novel bactericidal fabric coating with potent in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA)Int J Antimicrob Agents20093342743119112009
  • HoltzRDFilhoAGSBrocchiMMartinsDDuránNAlvesOLDevelopment of nanostructured silver vanadates decorated with silver nanoparticles as a novel antibacterial agentNanotechnology20102118
  • LaraHHAyala-NunezNVIxtepan-Tur rentLRodriguez-PadillaCMode of antiviral action of silver nanoparticles against HIV-1J Nanobiotechnology2010811020145735
  • Medina-RamirezIBashirbSLuoZGreen synthesis and characterization of polymer-stabilized silver nanoparticlesColloids Surf B Biointerfaces20097318519119539451
  • ShameliKAhmadMBYunusWMZWSynthesis and characterization of silver/talc nanocomposites using the wet chemical reduction methodInt J Nanomedicine2010574375121042420
  • DarroudiMAhmadMBShameliKSynthesis and characterization of UV-irradiated silver/montmorillonite nanocompositesSolid State Sci20091116211624
  • AhmadMBShameliKYunusWMZWSynthesis and characterization of silver/clay/starch bionanocomposites by green methodAust J Basic Appl Sci2010421582165
  • ShameliKAhmadMBYunusWMZWGreen synthesis of silver/montmorillonite/chitosan bionanocomposites using the UV irradiation method and evaluation of antibacterial activityInt J Nanomedicine2010587588721116328
  • AhmadMBShameliKDarroudiMSynthesis and characterization of silver/clay/chitosan bionanocomposites by UV-irradiation methodAm J Appl Sci2009620302035
  • SongKCLeeMSParkTSPreparation of colloidal silver nanoparticles by chemical reduction methodKorean J Chem Eng200926153155
  • AiharaNTorigoeKEsumiKPreparation and characterization of gold and silver nanoparticles in layered laponite suspensionsLangmuir19981449454949
  • XuG-NQiaoX-LQiuX-LPreparation and characterization of stable monodisperse silver nanoparticles via photoreductionColloids and Surfaces A2008320222226
  • LiuZWangHWangLXRed shift of plasmon resonance frequency due to the interacting Ag nanoparticle embedded in single crystal SiO2 by implantationAppl Phys Lett19987218231825
  • PatakfalviRAOszkaADekanyISynthesis and characterization of silver nanoparticles/kaolinite compositesColloids Surf A Physicochem Eng Asp20032204554
  • ShinHSYangHJKimSBMechanism of growth of colloidal silver nanoparticles stabilized by polyvinyl pyrrolidone in γ-irradiated silver nitrate solutionJ Colloid Interface Sci2004274899415120281
  • BarHBhuiDKSahooGPGreen synthesis of silver nanoparticles using latex ofJatropha curcas Colloids and Surf A2009339134139
  • AlemdarAGüngörNEceOIThe rheological properties and characterization of bentonite dispersions in the presence of non-ionic polymer PEGJ Mater Sci200540171177
  • GünisterEPestreliDÜnlüCHSynthesis and characterization of chitosan-MMT biocomposite systemsCarbohyd Polym200767358365
  • DarderMColillaMRuiz-HitzkyEBiopolymer-clay nanocomposites based on chitosan intercalated in montmorilloniteChem Mater20031537743780
  • BennTMWesterhoffPNanoparticle silver released into water from commercially available sock fabricsEnviron Sci Technol2008424133413918589977
  • ChudasamaBValaAVAndhariyaNEnhanced antibacterial activity of bifunctional Fe3O4 core-shell nanostructuresNano Res20092955965
  • ChenSFLiJPQianKLarge scale photochemical synthesis of M2TiO2 nanocomposites (M = Ag, Pd, Au, Pt) and their optical properties, CO oxidation performance, and antibacterial effectNano Res20103244255
  • MoronesJRElechiguerraJLCamachoAThe bactericidal effect of silver nanoparticlesNanotechnology2005162346235320818017
  • LeeDCohenRERubnerMFAntibacterial properties of Ag nanoparticle loaded multilayers and formation of magnetically directed antibacterial microparticlesLangmuir2005219651965916207049
  • JeongSHHwnagYHYiSCAntibacterial properties of padded PP/PE nonwovens incorporating nano-sized silver colloidsJ Mater Sci20054054135418